These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 35146577)

  • 1. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.
    Weber M; Lam M; Chiesa C; Konijnenberg M; Cremonesi M; Flamen P; Gnesin S; Bodei L; Kracmerova T; Luster M; Garin E; Herrmann K
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1682-1699. PubMed ID: 35146577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [
    Lopci E; Hicks RJ; Dimitrakopoulou-Strauss A; Dercle L; Iravani A; Seban RD; Sachpekidis C; Humbert O; Gheysens O; Glaudemans AWJM; Weber W; Wahl RL; Scott AM; Pandit-Taskar N; Aide N
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2323-2341. PubMed ID: 35376991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology.
    Veit-Haibach P; Ahlström H; Boellaard R; Delgado Bolton RC; Hesse S; Hope T; Huellner MW; Iagaru A; Johnson GB; Kjaer A; Law I; Metser U; Quick HH; Sattler B; Umutlu L; Zaharchuk G; Herrmann K
    Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3513-3537. PubMed ID: 37624384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based guideline of the European Association of Nuclear Medicine (EANM) on imaging infection in vascular grafts.
    Lauri C; Signore A; Glaudemans AWJM; Treglia G; Gheysens O; Slart RHJA; Iezzi R; Prakken NHJ; Debus ES; Honig S; Lejay A; Chakfé N
    Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3430-3451. PubMed ID: 35376992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNMMI Procedure Standard/EANM Practice Guideline for Brain [
    Arbizu J; Morbelli S; Minoshima S; Barthel H; Kuo P; Van Weehaeghe D; Horner N; Colletti PM; Guedj E
    J Nucl Med; 2024 Oct; ():. PubMed ID: 39419552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNMMI Procedure Standard/EANM Practice Guideline on Pediatric
    Vali R; Alessio A; Balza R; Borgwardt L; Bar-Sever Z; Czachowski M; Jehanno N; Kurch L; Pandit-Taskar N; Parisi M; Piccardo A; Seghers V; Shulkin BL; Zucchetta P; Lim R
    J Nucl Med; 2021 Jan; 62(1):99-110. PubMed ID: 33334912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.
    Giammarile F; Bodei L; Chiesa C; Flux G; Forrer F; Kraeber-Bodere F; Brans B; Lambert B; Konijnenberg M; Borson-Chazot F; Tennvall J; Luster M;
    Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1393-406. PubMed ID: 21494856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in France.
    Garin E; Pinaquy JB; Bailly C; Sengel C; Mariano-Goulart D; Edeline J; Blanc JF; Bouvier A; Tordo J; Rode A; Becker S; Sefrioui D; de Baere T; Somma C; Mastier C; Goupil J; Chevallier P; Regnault H; Vibert E; Manfredi S; Vicaut E; Patel B; Boucher E; Guiu B;
    Cardiovasc Intervent Radiol; 2022 Jan; 45(1):1-11. PubMed ID: 34796373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
    Wang EA; Stein JP; Bellavia RJ; Broadwell SR
    Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers.
    Coldwell D; Sangro B; Salem R; Wasan H; Kennedy A
    Am J Clin Oncol; 2012 Apr; 35(2):167-77. PubMed ID: 21127414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locoregional therapy for hepatocellular carcinoma: radioembolization with yttrium-90 microspheres.
    Herzer K; Müller S; Antoch G; Hilgard P
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):287-98. PubMed ID: 21769078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
    Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yttrium-90 resin microspheres and their use in the treatment of intrahepatic cholangiocarcinoma.
    Filippi L; Schillaci O; Cianni R; Bagni O
    Future Oncol; 2018 Apr; 14(9):809-818. PubMed ID: 29251517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yttrium 90 microspheres for the treatment of hepatocellular carcinoma.
    Memon K; Lewandowski RJ; Riaz A; Salem R
    Recent Results Cancer Res; 2013; 190():207-24. PubMed ID: 22941023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial.
    Smits ML; Nijsen JF; van den Bosch MA; Lam MG; Vente MA; Huijbregts JE; van het Schip AD; Elschot M; Bult W; de Jong HW; Meulenhoff PC; Zonnenberg BA
    J Exp Clin Cancer Res; 2010 Jun; 29(1):70. PubMed ID: 20550679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres.
    Haug AR; Heinemann V; Bruns CJ; Hoffmann R; Jakobs T; Bartenstein P; Hacker M
    Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1037-45. PubMed ID: 21308371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial Radioembolization (TARE) Agents beyond
    Bouvry C; Palard X; Edeline J; Ardisson V; Loyer P; Garin E; Lepareur N
    Biomed Res Int; 2018; 2018():1435302. PubMed ID: 30687734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis.
    Al-Adra DP; Gill RS; Axford SJ; Shi X; Kneteman N; Liau SS
    Eur J Surg Oncol; 2015 Jan; 41(1):120-7. PubMed ID: 25449754
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Nezami N; Kokabi N; Camacho JC; Schuster DM; Xing M; Kim HS
    Nucl Med Biol; 2018 Apr; 59():22-28. PubMed ID: 29448165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Segmental Yttrium-90 Radioembolization Using Glass Microspheres Greater than 400 Gray for the Treatment of Intrahepatic Cholangiocarcinoma: A Preliminary Experience.
    Yu Q; Patel M; Kwak D; Ungchusri E; Wang Y; Van Ha T; Zangan S; Marshall E; Little K; Baker T; Liao CY; Pillai A; Ahmed O
    J Vasc Interv Radiol; 2023 Nov; 34(11):1970-1976.e1. PubMed ID: 37532096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.